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Abstract: Spray-dried preparations from porcine and bovine plasma can alleviate mucosal
inflammation in experimental models and improve symptoms in patients with enteropathy.
In rodents, dietary supplementation with porcine spray-dried plasma (SDP) attenuates intestinal
inflammation and improves the epithelial barrier function during intestinal inflammation induced
by Staphylococcus aureus enterotoxin B (SEB). The aim of this study was to discern the molecular
mechanisms involved in the anti-inflammatory effects of SDP. Male C57BL/6 mice were fed with 8%
SDP or control diet (based on milk proteins) for two weeks, from weaning until day 33. On day 32,
the mice were given a SEB dose (i.p., 25 µg/mouse) or vehicle. SEB administration increased cell
recruitment to mesenteric lymph nodes and the percentage of activated Th lymphocytes and SDP
prevented these effects). SDP supplementation increased the expression of interleukin 10 (IL-10) or
transforming growth factor- β (TGF-β) compared to the SEB group. The SEB challenge increased
six-fold the expression of mucosal addressin cell adhesion molecule 1 (MAdCAM-1) and intercellular
adhesion molecule 1 (ICAM-1); and these effects were attenuated by SDP supplementation. SEB also
augmented NF-κB phosphorylation, an effect that was prevented by dietary SDP. Our results indicate
that the anti-inflammatory effects of SDP involve the regulation of transcription factors and adhesion
molecules that reduce intestinal cell infiltration and the degree of the inflammatory response.
Keywords: intestinal inflammation; S. aureus enterotoxin B; adhesion molecules; transcription factors;
dietary supplementation
1. Introduction
Stress, xenobiotics, food components, environmental toxins or changes in the microbiota may
trigger intestinal inflammation, which involves increased production of pro-inflammatory cytokines.
This inflammatory syndrome may be worsened by the genetic susceptibility of exposed individuals, as
observed in patients suffering inflammatory bowel diseases [1]. The inflammatory response is initiated
by the mucosal gut-associated lymphoid tissue (GALT), which is responsible for local responses as
well as for phenomena that occur in other mucosal regions, such as nasal-associated lymphoid and
genitourinary-associated lymphoid tissues [2].
It is well documented that colostrum and breast milk are a source of immunoglobulins and
other proteins that contribute to the early development of the immune system and that they have
protective tolerogenic and anti-inflammatory effects [3]. There is intensive research underway to
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characterize nutritional strategies for the therapeutic management of inflammatory syndromes [4].
Dietary supplements prepared from functional proteins derived from foodstuffs [5], from bovine
colostrum or milk [6], and from porcine or bovine animal plasma [7–9], have all been demonstrated
to be effective in the amelioration and even prevention of inflammation in numerous experimental
models. Recent evidence also indicates that functional protein supplements can be useful in the clinical
management of patients with enteropathy (reviewed by [10]).
Fewer models are available for studies focused on inflammation of the small intestine than for
the study of colitis syndromes, probably because the incidence of the former is much lower than
that of colonic inflammation syndromes. However, Crohn’s disease usually affects distal regions
of the small intestine and some inflammatory pathologies (e.g., those induced by some toxins and
xenobiotics) are restricted to the small intestine [11]. We previously characterized a model of mild
intestinal inflammation based on the acute administration of the Staphylococcus aureus enterotoxin B
(SEB). This toxin causes moderate GALT activation, stimulating cell recruitment and the production
of pro-inflammatory cytokines in both organized and diffuse GALT subsystems [7]. The limited
magnitude of the GALT response to the SEB challenge makes this model appropriate for the study of
dietary approaches that may have modulatory effects on signaling pathways. As a result of immune
activation, the expression of junctional proteins, such as zonula occludens-1 and β-catenin, is reduced,
which is consistent with the increased in luminal water contents and mucosal permeability [12].
SEB also reduces the expression of mucosal defensins [13] and SGLT1 abundance in villous apex [14].
Spray-dried plasma (SDP) of porcine and bovine origin have been widely used as dietary
supplements for farm animals at the time of weaning because they promote growth and reduce
both morbidity and mortality [15]. Studies of pigs challenged with pathogenic microorganisms
indicate that SDP has anti-inflammatory effects because it reduces the expression of pro-inflammatory
cytokines [16]. In our laboratory, we previously identified the lymphoid cell subsets as well as the
cytokines and chemokines involved in GALT stimulation that are eventually modulated by plasma
protein supplements [7,17]. In all instances, plasma supplements reversed the changes in the ratio of
activated-to-regulatory T-lymphocytes that is characteristic of inflammatory syndromes, and promoted
the expression of anti-inflammatory cytokines.
Studies of the mechanisms by which SDP mediates anti-inflammatory effects indicate that it
lowers the expression of mucosal pro-inflammatory cytokines, reduces activation of Th cells and
promotes abundance of the Treg subpopulation. Moreover, the production of anti-inflammatory
cytokines (typically interlekin 10 and transforming growth factor β) is also increased and this will
counteract the effects of TNF-α and other pro-inflammatory mediators. These changes in the cytokine
profile may explain the reduction (or even complete prevention) of the effects resulting from an SEB
challenge, namely: increased intestinal permeability, reduced defensin secretion and reduced intestinal
glucose uptake capacity.
Inflammatory syndromes are also characterized by cellular proliferation in susceptible tissues
because elevated concentrations of pro-inflammatory cytokines increase endothelial permeability
and facilitate lymphocyte extravasation [18]. The objective of the present study is to analyze the
mechanisms involved in the anti-inflammatory effects of SDP, measuring the expression of signaling
and regulatory molecules that enable lymphocyte infiltration into tissues, and the progression and
consolidation of the inflammatory syndrome.
2. Materials and Methods
2.1. Animals and Diets
Male C57BL/6 mice were supplied by Charles River (Lyon, France) and were kept at the Faculty
of Pharmacy’s animal house facility under conditions of constant temperature and humidity, with a
12 h:12 h light/dark cycle and with food and water available ad libitum. Ethical Committee for Animal
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Experimentation of the University of Barcelona’s and the Catalan government approved the protocols
used in this study (registration numbers 565/13 and 7397, respectively).
The animals were weaned at 19 days of age and distributed into experimental groups at random.
The groups were: (a) control group: mice fed the control diet; (b) SEB group: mice fed the control diet
and challenged with SEB; (c) SEB-SDP group: mice fed the SDP supplemented diet and challenged
with SEB. Animals were fed the experimental diets for 14 days and the composition of these diets are
detailed in Table 1. On day 32, mice were administered with the S. aureus enterotoxin B (SEB; 25 µg
i.p./mice; Toxin Technology, Sarasota, FL, USA) or vehicle, and 24 h later, mice were anesthetized by
i.p. administration of ketamine (90 mg/Kg; Imalgene®, Rhone Mèrieux, Lyon, France) and xilacine
(10 mg/kg; Rompun®, Bayer, Leverkusen, Germany) followed by cardiac puncture for exsanguination.
Table 1. Composition of experimental diets.
Ingredients Control Diet (g/kg) SDP 1 Diet (g/kg)
SDP - 80.0
Corn starch 199.3 272.5
Dried skim milk 530.7 376.4
Sugar 100.0 100.0
Soybean oil 70.0 70.7
Cellulose 50.0 50.0
AIN-93 VX 2 10.0 10.0
AIN-93 MX 2 35.0 35.0
DL-Methionine 2.5 2.9
Choline bitartrate 2.5 2.5
1 SDP (Spray-dried plasma) is provided by APC-Europe, Granollers, Spain; 2 AIN-93 VX, Vitamin mix;
AIN-93 MX, mineral mix. Both were provided by Harlan Ibérica, Barcelona, Spain.
2.2. Mesenteric Lymph Node Cell Isolation
The mesenteric lymph nodes were obtained, finely minced and incubated in the solution of
digestion composed by RPMI-1640 (Invitrogen, Carlsbad, CA, USA) with 5% inactivated fetal bovine
serum, 100,000 U/L penicillin, 100 mg/L streptomycin, 10 mM-HEPES, 2 nM-L-glutamine and
150 U/mL collagenase (Invitrogen, Carlsbad, CA, USA) at 37 ◦C in a shaker (Thermomixer Comfort
Eppendorf®, Heuppauge, NY, USA). The mesenteric lymph nodes were mechanically disaggregated
and passed through stainless steel mesh. The cell suspension was centrifuged at 500× g for 10 min
at 4 ◦C. The pelleted cells were resuspended in PBS-FBS. Cell number and viability were determined
using acridine orange and ethidium bromide.
2.3. Cell Staining
The procedure was performed as described before [19]. Briefly, the staining was carried out on
1.5 × 104 cells. To stain extracellular markers, cells were incubated with the primary antibodies for
30 min at 4 ◦C (Table 2). To stain the intracellular markers, cells were fixed with paraformaldehyde
and permeabilized with Triton-X® (Sigma, St. Louis, MO, USA). Then, cells were washed and
incubated with the primary antibodies to intracellular markers (Table 2). Finally, cells were washed and
maintained in paraformaldehyde until further analysis in the Gallios Flow cytometer (Beckman Coulter,
Miami, FL, USA), located at the Cytometry Unit of the Cientifico-Technical Services of the Barcelona
Science Park. Results were analyzed using the Flowjo Software (version 7.6.5, Treestar Inc., Ashland,
OR, USA). Lymphocytes and non-lymphocytic leucocytes were separated by forward/side scatter.
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Table 2. Antibodies used for cell staining.
Antigen Cell Subtype Clone Source
CD45 present in all leukocytes 30-F11 eBioscience
CD4 Th cells RM4-5 eBioscience
CD25 activated T lymphocytes PC61.5 eBioscience
Foxp3 regulatory T lymphocytes FJK-16s eBioscience
CD68 monocytes FA-11 Bio-Rad
Ly6G neutrophils 1A8 Becton Dickinson
CD14 activated neutrophils/monocytes Sa2-8 eBioscience
IL-4 Th2 lymphocytes 11B11 eBioscience
IFN-γ Th1 lymphocytes XMG1.2 eBioscience
IL-17 Th17 lymphocytes EbioTC11-18H10.1 eBioscience
Foxp3, forkhead box P3; IFN- γ, interferon γ; IL-4, interleukin 4; IL-17, interleukin 17; Th lymphocytes,
T helper lymphocytes. Becton Dickinson (Franklin Lake, NJ, USA); eBioscience (San Diego, CA, USA); Bio-Rad
(Hercules, CA, USA).
2.4. Western Blot Analysis
Western blot procedures were performed according to a previous study [20]. Samples of
jejunum mucosa were homogenized and protein concentration was determined using the Bradford
method (Bio-Rad, Hercules, CA, USA). Equal amounts of protein (100 µg) were separated on 10%
SDS-PAGE and transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA).
Membranes were incubated overnight at 4 ◦C with diluted primary antibodies against β-actin (clone
AC-74; 1:20,000; Sigma, St. Louis, MO, USA), Smad2/3 and its phosphorylated form p-Smad2/3
(clones D7G7 and D27F4, respectively, both 1:750; Cell Signaling Technology, Danvers, MA, USA) and
NF-κB and its phosphorylated form p-NF-κB (clones D14E12 and 93H1, respectively; both 1:1000;
Cell Signaling Technology, Danvers, MA, USA). Membranes were washed and incubated with
horseradish peroxidase (HRP)-conjugated secondary antibodies (Sigma, St. Louis, MO, USA) for
2 h at room temperature. Protein bands were visualized using a chemiluminescence detection kit
Clarity and ChemiDoc XRS+ instrument (both from Bio-Rad, Hercules, CA, USA). After their detection,
hybridization bands were quantified using ImageJ gel analyzer software [21].
2.5. Real-Time PCR Analysis
RNA extraction and reverse transcription were carried out as described previously [17].
RNA quality and quantity were assessed by spectrophotometry (NanoDrop ND-1000; ThermoFisher
Scientific, Waltham, MA, USA). Total RNA was retro-transcribed using iScript™ cDNA Synthesis
Kit (Bio-Rad, Hercules, CA, USA). For real-time PCR determinations, we used a template of
cDNA in a 20 µL reaction containing 0.2 µmol/L of each primer and SsoAdvanced™ Universal
SYBR® Green Supermix (Bio-Rad, Hercules, CA, USA). The primers used are listed in the Table 3.
Real-time PCR was performed on a MiniOpticon Real-Time PCR System (Bio-Rad, Hercules, CA, USA).
Each PCR run included duplicates of reverse transcription for each sample and negative controls
(reverse transcription-free samples, RNA-free sample). Quantification of the target gene transcripts
was done using hypoxanthine phosphoribosyltransferase 1 (HPRT1) gene expression as reference, and
was carried out with the 2−∆∆CT method [22]. Product fidelity was confirmed by melt-curve analysis.
2.6. Statistical Analysis
The data from the experiments are presented as the mean ± SEM. Previous research indicated
that 7 to 8 animals are enough to observe SDP effects on immune populations [19], while 4 to
5 samples are sufficient to detect changes in gene expression [17]. Mean values of normally distributed
data were compared using one-way ANOVA followed by Fisher least square difference (LSD) post
hoc test. Non-normally distributed variables and variables with non-homogeneous variances were
log-transformed before analysis. Log-transformed variables were then back-transformed for graphical
Nutrients 2016, 8, 657 5 of 13
representation. Statistical tests were performed using Prism (version 6.01, GraphPad Software, Inc., La
Jolla, CA, USA). Differences were considered significant at p < 0.05.
Table 3. Primers used for real time PCR.
Primer Forward (5′–3′) Reverse (5′–3′) FragmentSize
Accession
Number
Foxp3 TTCCTTCCCAGAGTTCTTCCAC ATGGCCCATCGGATAAGGGT 93 bp NM_001199347.1
HPRT1 TGGATACAGGCCAGACTTTGTT CAGATTCAACTTGCGCTCATC 163 bp NM_013556.2
ICAM-1 CAGTCGCTGTGCTTTGAGAA GAGGTCTCAGCTCCACACTCT 98 bp NM_010493.2
IFN-γ CCTTCTTCAGCAACAGCAAGGCG CTTGGCGCTGGACCTGTGGG 87 bp NM_008337.3
IL-1β TGTGAAATGCCACCTTTTGA GGTCAAAGGTTTGGAAGCAG 94 bp NM_008361.4
IL-10 GGCGCTGTCATCGATTTCTCCCC TGGCCTTGTAGACACCTTGGTCTT 102 bp NM_010548.2
Integrin β7 GTATCAGGAGCTGAGACAGTTGATT AGTCACAGTGGATGACAGGC 118 bp NM_013566.2
MAdCAM-1 CCCATGGCCACAGCTACCTCA CCCTGGCCCTAGTACCCTAC 85 bp NM_013591.2
TGF-β CAGTGGCTGAACCAAGGAGACGG CCCCGACGTTTGGGGCTGATC 119 bp NM_011577.1
TNF-α CCACCACGCTCTTCTGTCTAC AGGGTCTGGGCCATAGAACT 103 bp NM_013693.2
VCAM-1 CCTCGCTAGGTTACACAGTGG TGGGGGCAACGTTGACATA 86 bp NM_011693.3
Foxp3, forkhead box P3; HPRT1, hypoxanthine phosphoribosyltransferase 1; ICAM-1, intercellular adhesion
molecule 1; IFN- γ, interferon γ; Interleukin 1 β, IL-1 β; Interleukin 10, IL-10; MadCAM-1, mucosal addressin
cell adhesion molecule1; TGF- β, transforming growth factor β; TNF- α, Tumoral necrosis factor α; VCAM-1,
vascular cell adhesion protein 1.
3. Results
3.1. Lymphocyte Populations
SEB administration induced cell recruitment into mesenteric lymph nodes by 45% (p = 0.0291;
Figure 1A) and an SDP diet prevented this effect (p = 0.0101). Enterotoxin administration increased the
percentage of activated neutrophils and activated monocytes (p < 0.0001 and p = 0.0004; Figure 1B,C,
respectively). SDP supplementation completely prevented the SEB effects on the percentage of
activated neutrophils (p = 0.0032) and partially reduced the percentage of activated monocytes.
SEB challenge increased more than two-fold the percentage of activated lymphocytes (p < 0.0001;
Figure 1D) and had no effect on the percentage of regulatory Th (Treg) lymphocytes (Figure 1E),
increasing the ratio between activated and regulatory Th lymphocytes (p < 0.0001; Figure 1F). SDP
supplementation reduced the effect of SEB on the percentage of activated Th lymphocytes (p < 0.0001)
and increased the percentage of Treg (p = 0.0004), reducing the ratio between activated Th lymphocytes
and Treg (p < 0.0001). As for Th lymphocytes, enterotoxin administration increased the percentage of
Th1, Th2 and Th17 lymphocytes as well as the ratio between Th17/Treg lymphocytes (all p < 0.0001;
Figure 2) and SDP reduced SEB effects on the percentages of these Th subsets (Th2 lymphocytes,
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Figure 2. Percentage of Th1 lymphocytes (A); Th2 lymphocytes (B); Th17 lymphocytes (C);
and Th17/Treg lymphocytes (D) ratio in mesenteric lymph nodes from Control, SEB and SEB-SDP mice.
Lymphocyte subsets were detected by flow cytometry, CD4+IFN-γ+ for Th1 lymphocytes, CD4+IL-4+
for Th2 lymphocytes and CD4+IL-17+ for Th17 lymphocytes. IFN-γ, interferon γ. Data were compared
by ANOVA followed by Fisher LSD post hoc multiple-comparison tests. All of the results are expressed
as mean ± SEM (n = 7–8 animals). Means without a common letter differ, p < 0.05.
3.2. Cytokine Expression
The enterotoxin increased the expression of pro-inflammatory cytokines TNF-α, IFN-γ and IL-1β
in jejunum mucosa (p = 0.0020, p = 0.0190 and p = 0.0023, respectively; Figure 3A–C) and SDP diet
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attenuated this effect on TNF-α and IL-1β (p = 0.0074 and p = 0.0057, respectively). SEB administration
did not change the expression of IL-10 and TGF-β (Figure 3D,E), but SDP supplementation increased
the expression of both cytokines compared to SEB group (p = 0.0231 and p = 0.0013, respectively).
Enterotoxin administration decreased Foxp3 expression in jejunum mucosa and SDP diet attenuated
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Figure 3. ex ression of TNF-α (A); IFN-γ (B); IL-1β (C); IL-10 (D); TGF-β (E) and Foxp3
(F) in jejunum mucosa from Control, SEB and SEB-SDP mice. All target genes were normalized to
hypoxanthine phosphoribosyltransferase 1 (HPRT1) expression. TNF- α; tumoral necrosis factor α;
IL-1β, interleukin 1 β; IL-10, interleukin 10. Data were compared by ANOVA followed by Fisher LSD
post hoc multiple-comparison tests. All the results are expressed as mean ± SEM (n = 4–5 animals).
Means without a common letter differ, p < 0.05.
3.3. Expression of Adhesion Molecules
SEB administration increased the expression of mucosal addressin cell adhesion molecule 1
(MAdCAM-1) and intercellular adhesion molecule 1 (ICAM-1) (p = 0.0073 and p = 0.0052, respectively;
Figure 4A,B) six-fold. It also induced a modest but significant increase in vascular cell adhesion
molecule 1 (VCAM-1) expression and a two-fold increase in the expression of integrin β7 in intestinal
mucosa (p = 0.0190 and p = 0.0072, respectively; Figure 4C,D). SDP supplementation preve ted an SEB
effect on the expression of the adh ion molecules MAdCAM-1, ICAM-1 and integrin β7 (p = 0.0198,
p = 0.0385 and p = 0.0217, respectively).
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3.4. Expression of Transcription Factors
The total mount of Smad2/3 and NF-κB was not modified by the enterotoxin nor by
SDP supplementation since all groups showed similar value (Figure 5A,C). On the other hand,
administration of SEB decreased phosphorylation of Smad2/3 (p = 0.0066; Figure 5B) and increased
NF-κB phosphorylation (p = 0.0010; Figure 5D). SDP supplementation prevented the effect of SEB
administration on both transcription factors (Smad2/3 phosphorylation p = 0.0016, and NF-κB
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The  total  amount  of  Smad2/3  and NF‐κB was  not modified  by  the  enterotoxin  nor  by  SDP 
supplementation  since  all  groups  showed  similar  value  (Figure  5A,C).  On  the  other  hand, 
administration of SEB decreased phosphorylation of Smad2/3 (p = 0.0066; Figure 5B) and increased 
NF‐κB phosphorylation  (p = 0.0010; Figure 5D). SDP supplementation prevented  the effect of SEB 





P‐Smad2/3,  phosphorylated  Smad2/3;  NF‐κB,  nuclear  factor  kappa  B;  p‐NF‐κB,  phosphorylated 
nuclear factor kappa B. Data were compared by ANOVA followed by Fisher LSD post hoc multiple‐
comparison tests. Means without a common letter differ, p < 0.05. 
Figure 5. Muc sal amount of Smad2/3 (A); p-Smad2/3 (B); NF-κB (C) p-NF-κB (D) in jejunum
mucosa from Control, SEB and SEB-SDP mice. All the results are expressed as mean ± SEM
(n = 4–5 animals). P-Smad2/3, phosphorylated Smad2/3; NF-κB, nuclear factor kappa B; p-NF-κB,
phosphorylated nuclear factor kappa B. Data were compared by ANOVA followed by Fisher LSD post
hoc multiple-comparison tests. Means without a common letter differ, p < 0.05.
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4. Discussion
Dietary supplements prepared from animal plasma are administered to farm animals to minimize
the impact of the stress associated with early weaning [5]. Preparations from porcine or bovine
plasma can enhance the health and performance of young animals, due in part to improvements in
gut barrier function, normalization of cytokine signals, and support of enteric immune function [23].
Several studies have aimed to discover the mechanisms involved in the anti-inflammatory effects
of these and other immunoglobulin-rich preparations (e.g., milk-derived proteins). Among other
mechanisms [24], their capacity to maintain a homeostatic immune balance in the gastrointestinal
mucosa must be part of the explanation.
We previously demonstrated that SDP reduces the alterations observed in mucosal
permeability [25], in epithelial defensin secretion [13], and in glucose uptake capacity [14], which
are induced by an SEB challenge. In the present study, we use this well-consolidated model to
further explore the effects of SDP on the mucosal expression of cytokines and to analyze whether this
supplement can regulate the pathways that signal the infiltration and activation of lymphocytes into
the mucosa.
In mice, the SEB challenge induces intestinal inflammation with features that are similar to those
previously described in the rat [12]. In both species, SEB increases infiltration of immune cells into
intestinal mucosa and enhances production of pro-inflammatory cytokines, without affecting the
histology of the jejunum or systemic (immune) variables. In mice, SEB increased leukocyte recruitment
to mesenteric lymph nodes and activation of lymphoid cell populations, thereby confirming previous
results [26]. The percentage of T-activated lymphocytes was increased while the T-regulatory
subpopulation was not modified, indicating that the change in the Tact/Treg ratio is due to proliferation
of the Tact population. The same lymphocyte profile was observed in the colon of mice that
spontaneously develop colitis [9].
SEB also increases the percentage of the main Th subsets, namely Th1, Th2 and Th17,
consistent with polyclonal stimulation of Th lymphocytes by this enterotoxin [27]. The expression of
pro-inflammatory TNF-α and IFN-γ cytokines also increased, as already observed in other models
of intestinal inflammation [28]. Increased expression of IL-1β will prime and amplify subsequent
intestinal immune responses [29]. This cytokine, acting in concert with other pro-inflammatory
cytokines, stimulates Th17 cell differentiation [30] and this, in turn, promotes neutrophil migration to
inflammatory sites [31].
SDP supplementation attenuated both innate and acquired immune activation, reducing the
percentage of activated neutrophils as well as the relative number of activated Th lymphocytes.
Furthermore, SDP reduced the toxin-induced proliferation of Th1, Th2 and Th17 lymphocytes, and
also prevented the effects of SEB on the mucosal expression of TNF-α and IL-1β. These effects of SDP
are relevant since both TNF-α and IL-1β can induce neutrophilia and neutrophil activation [32].
SDP supplementation also returned the Tact/Treg ratio to control values, confirming previous
observations induced by plasma proteins in the inflamed colon mucosa [9] and in the lung and blood
of mice challenged with lipopolysaccharide [19]. These effects on the ratio of activated-to-regulatory
T-cells are paralleled by changes in the expression of pro- and anti-inflammatory cytokines. Indeed,
SDP appears to play a dual role in preventing the SEB-stimulated expression of TNF-α and IL-1β,
while increasing 2–3 fold the expression of anti-inflammatory IL-10 and TGF-β cytokines. TGF-β and
IL-10 regulate proliferation and differentiation of lymphocytes, phagocytes, dendritic cells and oral
tolerance, and thereby modulate the inflammatory response [33]. Another important indicator of the
inflammation condition is the Th17/Treg ratio, as it is considered to be critical for host immunity
and plays an important role in tolerance preservation and also in autoimmune diseases, including
inflammatory bowel diseases [34,35].
Tregs are responsible for maintaining immune homeostasis and suppressing intestinal
inflammation resulting from aberrant immune responses to self-antigens and commensal bacteria [34].
The expression of signature transcription factor forkhead box p3 (Foxp3) is indispensable for Treg
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to carry out their anti-inflammatory function [35]. In exploring a possible mechanistic pathway, we
found that SDP treatment recovered the otherwise low Foxp3 expression found in SEB-challenged
mice. Similar effects of plasma protein supplements were observed in the colitis mouse model [9] and
in the acute lung inflammation model [8].
A key step in the progression of inflammation is lymphocyte migration into tissues. The SEB
challenge stimulates the release of inflammatory mediators and the recruitment of circulating
leukocytes, which become activated at the site of inflammation and then stimulate a further release of
inflammatory mediators. T cells primed in Peyer’s patches and mesenteric lymph nodes preferentially
express α4β7-integrin, while endothelial cells of venules present in the intestinal mucosa constitutively
express MAdCAM-1, which is a ligand for α4β7-integrin. This will allow newly induced lymphoid
tissue to enter its mucosal effector sites [36].
TNF-α induces the expression of MAdCAM-1 in the small and large intestine, and in mesenteric
lymph nodes [37], via a mechanism that requires tyrosine kinases, p38 mitogen-activated protein
kinases, and NF-κB [38]. TNF-α and other pro-inflammatory cytokines also stimulate the expression
of adhesion molecule receptors and ligands such as VCAM-1 and ICAM-1, which will result in a
sustained influx of inflammatory cells [39]. VCAM-1 expression in the gut microvasculature is directly
proportional to leukocyte infiltration and histological damage [40] and is regulated by the PI3K/NF-κB
signaling pathway [41]. NF-κB activation also plays a predominant role in the induction of ICAM-1
gene expression by TNF-α and thrombin in endothelial cells [42].
SDP supplementation reduced the expression of TNF-α and IL-1β, as well as the phosphorylation
of NF-κB, suggesting a possible mechanistic pathway of SDP immune modulation, since
immunoneutralization of MAdCAM-1, or its leukocyte counter-receptor integrin α4β7, has been shown
to result in significant clinical benefits in experimental and human inflammatory bowel disease [43,44].
Reduction in ICAM-1 expression would explain previous results using the mouse colitis model in
which plasma protein supplementation reduced leukocyte infiltration into the colon mucosa [9,17].
Other supplements with anti-inflammatory properties, such as ginkgo leaf extracts [45], or drugs such
as the β-adrenergic antagonist carvedilol [46] can also inhibit endothelial adhesion to monocytes by
reducing VCAM-1 expression via suppression of NF-κB signaling pathways.
TGF-β regulates tight-junction proteins and the permeability properties of the mucosa, which
determines the severity of the inflammatory syndrome [47]. The observation that SDP supplementation
increases the expression of TGF-β could explain the improvement in barrier function observed in
rats challenged with SEB [24] and in mice that develop colitis [9,17]. The role of TGF-β in barrier
function is partially mediated by Smad2/3 signaling pathways [47]. Our results show that SEB
reduces the phosphorylated form of Smad2/3 and SDP reversed this effect. Consequently, we can
tentatively conclude that the protective effect of SDP on the intestinal epithelial barrier observed in
different experimental models of intestinal inflammation involves TGF-β canonical Smad pathways.
Xiao et al. [48] also show, in a model of intestinal inflammation induced by lipopolysaccharide, that a
whey protein concentrate protects intestinal integrity via a mechanism that also involves TGF-β and
phosphorylation of the Smad2/3 complex pathway.
SDP is thus shown to have anti-inflammatory effects by reducing the expression of
pro-inflammatory cytokines and both the proliferation and expansion of lymphocyte populations in
intestinal and peripheral tissues. Although the initial steps that connect SDP components with GALT
populations are still not completely understood, they probably involve bioactive peptides present in
plasma, a reduction of the luminal antigen charge and promotion of a beneficial microbiota profile.
Whatever the trigger is, what we now know is that SDP prevents lymphocyte migration into tissues
while reducing the expression of adhesion molecules via mechanisms involving phosphorylation of
specific signaling pathways. Moreover, SDP can also reduce NF-κB phosphorylation, which is a key
regulator of important inflammatory cascades.
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5. Conclusions
Our findings indicate that the anti-inflammatory effects of SDP involve a reduction in the
expression of adhesion molecules which decreases mucosal cell infiltration. Moreover, SDP can
reduce NF-κB phosphorylation, resulting in a reduction in leukocyte activation. These results support
the view that oral supplements rich in immunoglobulins and bioactive peptides may play a role in
restoring mucosal homeostasis when challenged by pro-inflammatory antigens and pathogens.
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